IndraLab

Statements


Nifekalant inhibits KCNH2. 1 / 1
| 1

reach
"Thus, nifekalant inhibits HERG channels in a voltage dependent and frequency dependent manner, and the inhibitory effect may underlie the clinical efficacy of the drug against ventricular tachyarrhythmias."